title: Commentary on Kaneko et al.: Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification.
authors.forename: Garrett M
authors.initials: GM
authors.lastname: Brodeur
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002675:Child, Preschool; D018572:Disease-Free Survival; D005784:Gene Amplification; D016259:Genes, myc; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007223:Infant; D009447:Neuroblastoma / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000628:therapy; D011379:Prognosis; D015996:Survival Rate; D019172:Transplantation Conditioning; D016896:Treatment Outcome